for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

India's Cipla gets regulator nod to import Moderna's COVID-19 vaccine - CNBC-TV18

June 29 (Reuters) - India’s Cipla Ltd has received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by Moderna Inc for restricted emergency use, CNBC-TV18 reported on Tuesday. (Reporting by Mrinalika Roy in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up